Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7): a028035.
PubMed PubMed Central Article CAS Google Scholar
Checkoway H, Lundin JI, Kelada SN. Neurodegenerative diseases. IARC Sci Publ. 2011;163:407–19.
Kovacs GG. Concepts and classification of neurodegenerative diseases. In: Handbook of clinical neurology. New York: Elsevier; 2018. p. 301–7.
Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, et al. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Cell Mol Biol Lett. 2022;27(1):10.
CAS PubMed PubMed Central Article Google Scholar
Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discovery. 2004;3(3):205–14.
CAS PubMed Article Google Scholar
Amor S, Puentes F, Baker D, Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129(2):154–69.
CAS PubMed PubMed Central Article Google Scholar
Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995;38(3):357–66.
CAS PubMed Article Google Scholar
Durães F, Pinto M, Sousa E. Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals. 2018;11(2):44.
PubMed Central Article CAS Google Scholar
Sakthiswary R, Raymond AA. Stem cell therapy in neurodegenerative diseases: from principles to practice. Neural Regen Res. 2012;7(23):1822.
PubMed PubMed Central Google Scholar
Lunn JS, Sakowski SA, Hur J, Feldman EL. Stem cell technology for neurodegenerative diseases. Ann Neurol. 2011;70(3):353–61.
CAS PubMed PubMed Central Article Google Scholar
Torrente Y, Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant. 2008;17(10–11):1103–13.
Chen X, Wang S, Cao W. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases. Cell Immunol. 2018;326:8–14.
CAS PubMed Article Google Scholar
Witkowska-Zimny M, Wrobel E. Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion. Cell Mol Biol Lett. 2011;16(3):493–514.
PubMed PubMed Central Article Google Scholar
Rodríguez-Pardo VM, Vernot JP. Mesenchymal stem cells promote a primitive phenotype CD34+c-kit+ in human cord blood-derived hematopoietic stem cells during ex vivo expansion. Cell Mol Biol Lett. 2013;18(1):11–33.
PubMed Article CAS Google Scholar
Ahani-Nahayati M, Shariati A, Mahmoodi M, Olegovna Zekiy A, Javidi K, Shamlou S, Mousakhani A, Zamani M, Hassanzadeh A. Stem cell in neurodegenerative disorders; an emerging strategy. Int J Develop Neurosci. 2021;78:5.
Lin R, Li M, Luo M, Teng T, Pan Y, Huang H. Correction to: Mesenchymal stem cells decrease blood–brain barrier permeability in rats with severe acute pancreatitis. Cell Mol Biol Lett. 2019;24(1):56.
PubMed PubMed Central Article CAS Google Scholar
Kim SH, Oh K-W, Jin HK, Bae J-S. Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases. BMB Rep. 2018;51(11):545.
CAS PubMed PubMed Central Article Google Scholar
Lo Furno D, Mannino G, Giuffrida R. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases. J Cell Physiol. 2018;233(5):3982–99.
CAS PubMed Article Google Scholar
Li Q, Yu P, Wang W, Zhang P, Yang H, Li S, Zhang L. Gene expression profiles of various cytokines in mesenchymal stem cells derived from umbilical cord tissue and bone marrow following infection with human cytomegalovirus. Cell Mol Biol Lett. 2014;19(1):140–57.
CAS PubMed PubMed Central Article Google Scholar
Gorabi AM, Kiaie N, Barreto GE, Read MI, Tafti HA, Sahebkar A. The therapeutic potential of mesenchymal stem cell–derived exosomes in treatment of neurodegenerative diseases. Mol Neurobiol. 2019;56(12):8157–67.
CAS PubMed Article Google Scholar
Tatullo M, Codispoti B, Spagnuolo G, Zavan B. Human periapical cyst-derived stem cells can be a smart “lab-on-a-cell” to investigate neurodegenerative diseases and the related alteration of the exosomes’ content. Brain Sci. 2019;9(12):358.
CAS PubMed Central Article Google Scholar
Chen C, Huang H, Hu W, Li X. Mesenchymal stem cell-derived exosomes for the treatment of neurodegenerative diseases: existing problems and prospects in application. Chin J Tissue Eng Res. 2019;23(9):1441.
Wang X, Zhou Y, Gao Q, Ping D, Wang Y, Wu W, Lin X, Fang Y, Zhang J, Shao A. The role of exosomal microRNAs and oxidative stress in neurodegenerative diseases. Oxid Med Cell Longevity. 2020;2020:1.
Wei H, Xu Y, Chen Q, Chen H, Zhu X, Li Y. Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis. Cell Death Dis. 2020;11(4):290.
CAS PubMed PubMed Central Article Google Scholar
Miyanaga T, Ueda Y, Miyanaga A, Yagishita M, Hama N. Angiogenesis after administration of basic fibroblast growth factor induces proliferation and differentiation of mesenchymal stem cells in elastic perichondrium in an in vivo model: mini review of three sequential republication-abridged reports. Cell Mol Biol Lett. 2018;23(1):49.
PubMed PubMed Central Article CAS Google Scholar
Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2(10):734–44.
CAS PubMed Article Google Scholar
Fan L, Mao C, Xu Y, Shi C, Hu X, Zhang S, Yang Z, Hu Z, Sun H, Fan Y. New insights into the pathogenesis of Alzheimer’s disease. Front Neurol. 2019;10:1312.
Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280(7):5892–901.
CAS PubMed Article Google Scholar
Viola KL, Klein WL. Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol. 2015;129(2):183–206.
CAS PubMed PubMed Central Article Google Scholar
Bisht K, Sharma K, Tremblay M. Chronic stress as a risk factor for Alzheimer’s disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiol Stress. 2018;9:9–21.
PubMed PubMed Central Article Google Scholar
Poston KL, Ua Cruadhlaoich MA, Santoso LF, Bernstein JD, Liu T, Wang Y, Rutt B, Kerchner GA, Zeineh MM. Substantia nigra volume dissociates bradykinesia and rigidity from tremor in Parkinson’s disease: a 7 Tesla imaging study. J Parkinsons Dis. 2020;10(2):591–604.
PubMed PubMed Central Article Google Scholar
Klockgether T. Parkinson’s disease: clinical aspects. Cell Tissue Res. 2004;318(1):115–20.
Shulman JM, Jager PLD, Feany MB. Parkinson’s disease: genetics and pathogenesis. Annu Rev Pathol. 2011;6(1):193–222.
CAS PubMed Article Google Scholar
Doherty KM, Silveira-Moriyama L, Parkkinen L, Healy DG, Farrell M, Mencacci NE, Ahmed Z, Brett FM, Hardy J, Quinn N, et al. Parkin disease: a clinicopathologic entity? JAMA Neurol. 2013;70(5):571–9.
PubMed PubMed Central Article Google Scholar
Baudic S, Maison P, Dolbeau G, Boissé M-F, Bartolomeo P, Dalla Barba G, Traykov L, Bachoud-Lévi A-C. Cognitive impairment related to apathy in early Huntington’s disease. Dement Geriatr Cogn Disord. 2006;21(5–6):316–21.
Arrasate M, Finkbeiner S. Protein aggregates in Huntington’s disease. Exp Neurol. 2012;238(1):1–11.
CAS PubMed Article Google Scholar
Huang WJ, Chen WW, Zhang X. Huntington’s disease: molecular basis of pathology and status of current therapeutic approaches. Exp Ther Med. 2016;12(4):1951–6.
CAS PubMed PubMed Central Article Google Scholar
Liu-Yesucevitz L, Bilgutay A, Zhang Y-J, Vanderwyde T, Citro A, Mehta T, Zaarur N, McKee A, Bowser R, Sherman M. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5(10): e13250.
PubMed PubMed Central Article CAS Google Scholar
Fang MY, Markmiller S, Vu AQ, Javaherian A, Dowdle WE, Jolivet P, Bushway PJ, Castello NA, Baral A, Chan MY, et al. Small-molecule modulation of TDP-43 recruitment to stress granules prevents persistent TDP-43 accumulation in ALS/FTD. Neuron. 2019;103(5):802-19.e11.
留言 (0)